Comprehensive coverage

A soft exoskeleton suit will help rehabilitate stroke victims

ReWalk Robotics launches clinical research on the ReStore system, a soft exoskeleton suit. The clinical research that will be carried out with the new suit is intended for the rehabilitation of stroke victims and will provide clinical data for submitting the product to the FDA

Revok Robotics, which manufactures a robotic exoskeleton, announced the official launch of clinical research in the soft suite system called ReStore, which is designed to rehabilitate patients suffering from disabilities in the lower limbs following a stroke.

The first participant in the clinical study began using the ReStore last week at Spaulding Rehabilitation Hospital in Boston, Massachusetts, where the study is being led by a team of researchers from Boston University's Sargent College of Health and Rehabilitation Sciences. The clinical study aims to recruit 40 participants in five of the leading rehabilitation hospitals in the US.

"The launch of the clinical study is a significant advance in our efforts to offer the ReStore system as a commercial product for the rehabilitation of stroke victims worldwide," said Revok Robotics CEO Larry Jasinski. "We are excited to continue our collaboration with Spaulding, a well-known rehabilitation facility, and provide patients with access to this sophisticated technology."

The soft suit system, the first of its kind, which was unveiled in 2017, is part of the company's ambitions to develop new technologies that will serve patients with lower limb disabilities. According to the company, the ReStore suit is intended to be used as a versatile and cost-effective walking solution that allows the care team to provide rehabilitation treatment at the same time as real-time analytical analysis of the information collected by the system and the ability to personalize each patient.

"The ReStore suit is an innovative device that may bring about a change in the way we treat walking impairments following a stroke," said Dr. Lou Awad, Doctor of Physical Therapy, Associate Professor in the College of Health and Rehabilitation Sciences at Boston University and a member of the research team at the Spaulding Institute for Stroke Research and Recovery in Boston. Dr. Lou Awad serves as the lead researcher in this study. "We are excited to work with the industry leader, ReWalk Robotics, in launching the first clinical trial of this innovative rehabilitation technology."

The commercial product launch of the ReStore suit is planned for the first half of 2019. Rivek plans to market the ReStore system in Europe and the US subject to receiving CE and FDA approvals.

Leave a Reply

Email will not be published. Required fields are marked *

This site uses Akismat to prevent spam messages. Click here to learn how your response data is processed.